Last reviewed · How we verify
non-cystic fibrosis bronchiectasis
Approved treatments
- Brinsupri · Insmed Inc
Brinsupri works by inhibiting the activity of a protein that contributes to airway damage and inflammation. - Brinsupri · Insmed Inc
Brinsupri works by inhibiting the activity of a protein that contributes to airway damage and inflammation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- non-cystic fibrosis bronchiectasis patent landscape — cliff calendar, originator estates, attackable patents
- non-cystic fibrosis bronchiectasis treatment landscape brief
- non-cystic fibrosis bronchiectasis treatment updates RSS
Frequently asked questions about non-cystic fibrosis bronchiectasis
What drugs treat non-cystic fibrosis bronchiectasis?
Tracked treatments include Brinsupri.
What is the treatment for non-cystic fibrosis bronchiectasis?
Standard treatment for non-cystic fibrosis bronchiectasis includes Brinsupri. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: non-cystic fibrosis bronchiectasis patent cliff · non-cystic fibrosis bronchiectasis CI report
- Treatment: Brinsupri · Insmed Inc
- Treatment: Brinsupri · Insmed Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing